Code | 7675D | ||||||||
MA number | 09/0142/21-S | ||||||||
Product Form: | tbl mnd 48x625 mg/73,5 mg/150 mg (strip LDPE/Al) | ||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||
Type of procedure: | Mutual recognition procedure | ||||||||
Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||
ATC: |
|
||||||||
Shelf life: | 36 | ||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product not subject to medical prescription. |
Legal basis: | Article 10a well-established use application |
MA issued: | 26.05.2021 |
Validity: | 26.05.2026 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
SPC: | SPC_Rennie Plus 625 mg_73,5 mg_150 mg žuvacie tablety_05_2021.pdf |
PIL: | PIL_Rennie Plus 625 mg_73,5 mg_150 mg žuvacie tablety_05_2021.pdf |
Safety feature | No |
Data update: | 28.05.2021 |